USE OF R- (Z) -ALFA- (METOXIIMINO) -ALFA- (1-AZABICICLO (2.2.2) OCT-3-IL) ACETONITRILE TO REDUCE THE FORMATION OF AMILACEA BETA A4 PROTEIN IN THE DISEASE OF ALZHEIMER.

摘要

METHOD FOR IMPROVING THE PROCESS OF THE AMYLOID PRECURSOR PROTEIN THROUGH A NON-AMYLOIDOGENIC TRAJECTORY IN PATIENTS WHO SUFFER, OR ARE PROUD TO SUFFER, THE ALZHEIMER'S DISEASE AND METHOD TO TREAT OR PREVENT THE DISEASE OF THE DISEASE OF THE MEDIUM REDUCTION {BE} A4 IN PATIENTS WHO SUFFER, OR ARE LIKELY TO SUFFER, ALZHEIMER'S DISEASE AND THAT ASSUMES THE PATIENT'S ADMINISTRATION OF A NON-TOXIC, EFFECTIVE AMOUNT, OF A COMPOSITE OF ACETONITRILE, THE USE OF THE COMPOSITION IN THE PREPARATION OF A MEDICATION TO USE IN THE METHOD AND A COMPOSITION TO USE IN THE METHOD.